Full-Time

Admissions Specialist

Posted on 10/3/2025

Equip Health

Equip Health

501-1,000 employees

Virtual multidisciplinary treatment for eating disorders

Compensation Overview

$58k - $62k/yr

No H1B Sponsorship

Remote in USA

Remote

Candidates must be based in the United States.

Category
Customer Experience & Support (1)
Required Skills
Sales
Requirements
  • 1+ years experience working in mental health admissions or a sales related role.
  • Degree in psychology, business administration, or other health related fields preferred.
  • Strong interpersonal skills, phone presence, and adept at building strong working relationships.
  • Key analytical abilities to collect, analyze, and use Admissions data to learn and improve.
  • Strong understanding of the healthcare landscape.
  • Excellent organizational awareness, adaptability, and conflict management skills.
  • A passion for living our mission and values.
  • Spanish speaking is a plus.
Responsibilities
  • Consistently meet or exceed assigned targets by effectively fielding all inbound inquiries such as hand-offs from the Admissions Inquiry team or direct referrals from providers.
  • Collect and document all relevant data into Equip’s proprietary EMR software in a timely manner.
  • Coordinate with internal teams to meet the needs of patients and their families, monitor medical records, and ensure patients meet admissions criteria.
  • Foster relationships with referring providers by being the 'expert' in Equip Health.
  • Utilize problem solving and sales skills to maintain urgency and drive to seek treatment.
  • Monitor medical records and collaborate with Medical Directors on admissions criteria.
  • Adhere to HIPAA compliance in managing the collection of personal health information, insurance information, financial details, and other sensitive information.
  • Ethically and empathetically relate to patients and families throughout the admissions process.
  • Perform other duties as assigned.
Desired Qualifications
  • Degree in psychology, business administration, or other health related fields preferred.
  • Spanish speaking is a plus.

Equip Health offers telehealth, evidence-based treatment for eating disorders delivered virtually through at-home care. A multidisciplinary 5-person care team (therapist, physician, dietitian, family mentor, and peer mentor) provides a holistic program that includes individual and family therapy, medical monitoring, nutritional counseling, and peer support. Insurance-covered services make the treatment accessible, and the model is designed for early intervention to improve recovery outcomes and reduce relapse. The company differentiates itself by merging clinical expertise with lived experience to tailor care, aiming to guide patients toward full recovery and long-term well-being.

Company Size

501-1,000

Company Stage

Late Stage VC

Total Funding

$156.4M

Headquarters

San Diego, California

Founded

2019

Simplify Jobs

Simplify's Take

What believers are saying

  • Equip raised $47 million in 2025, boosting total funding to $156 million with Kerry Washington investing.
  • NEDA lists Equip as a top virtual treatment option, driving insurance-covered patient referrals.
  • Cigna and Regence contracts expand Equip's in-network access for family-based telehealth nationwide.

What critics are saying

  • GLP-1 drugs like Ozempic cut Equip's binge eating demand by 60-80% within 6-12 months.
  • Within Health undercuts Equip at $1,800/month with AI triage, eroding 70% insurance edge in 6-12 months.
  • CMS mandates in-person monitoring for severe anorexia, referring 80% of Equip's cases in 18-24 months.

What makes Equip Health unique

  • Equip deploys five-person teams of dietitians, physicians, therapists, and mentors for virtual eating disorder recovery.
  • Equip blends clinical expertise with lived recovery experience in its evidence-based home treatment model.
  • Equip Academy partners with TPN.health to deliver free CE credits on eating disorders live or on-demand.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Equip Health who can refer or advise you

Benefits

Flexible PTO & work hours

WFH or close to it

Home office stipend

Parental leave

Medical, vision, & dental

HSA & FSA

401k

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

3%

2 year growth

2%
intelligence360
Sep 10th, 2025
Equip Health Raises $46.6M Funding

Equip Health has filed a notice with the U.S. Securities and Exchange Commission for an exempt offering of securities to raise $46.6 million in new funding. This filing is required under federal securities law for companies selling securities without registration under the Securities Act of 1933, specifically under Rule 504 or 506 of Regulation D or Section 4(a)(5). The notice must be filed within 15 days after the first sale of securities in the offering.

Securities and Exchange Commission
Aug 2nd, 2025
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

Endpoints News
Aug 1st, 2025
Equip Health raises $47M funding

Virtual eating disorder treatment startup Equip has raised $47 million in new funding. The funding round was led by private equity.

Endpoints News
Aug 1st, 2025
Eating disorder telehealth startup Equip raises $47M

Virtual eating disorder treatment startup Equip has secured $47 million in new funding, Endpoints News has learned.

Behavioral Health Business
Aug 1st, 2025
Equip Health Raises $47M Funding

Equip Health, a virtual eating disorder treatment provider, raised $47 million in equity, bringing its total funding to $156 million, as per SEC filings. The Carlsbad, CA-based company had 11 investors in this round, starting on July 22. Actress Kerry Washington is an investor and advisor. The digital health model addresses challenges in eating disorder treatment, amid rising concerns over fitness culture and weight-loss drugs. The company has not commented on the funding.

INACTIVE